<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Immunophenotyping of <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> represents one of the most relevant clinical applications of flow cytometry </plain></SENT>
<SENT sid="1" pm="."><plain>Classically, leukemic/lymphomatous cells have been considered to reflect the immunophenotypic characteristics of different precursors and mature healthy cells blocked at certain differentiation stages </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, accumulating evidence has shown that neoplastic cells display several aberrant phenotypic patterns </plain></SENT>
<SENT sid="3" pm="."><plain>These aberrant phenotypes are believed to reflect genetic abnormalities present in pathologic cells, and recent data have shown that at least in <z:hpo ids='HP_0002488'>acute leukemias</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, and <z:e sem="disease" ids="C1136084" disease_type="Neoplastic Process" abbrv="">plasma cell dyscrasias</z:e>, they may be present in almost <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this work is to review recent advances in flow cytometry and the role of gating strategies more useful in the identification and characterization of neoplastic cells of different <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
</text></document>